CE mark awarded

Article

Oertli?s new surgical platform Faros, has received its CE mark after meeting EU consumer safety, health or environmental requirements. This important step for the platform keeps it on schedule for an expected March 2010 release.

Oertli’s new surgical platform Faros, has received its CE mark after meeting EU consumer safety, health or environmental requirements. This important step for the platform keeps it on schedule for an expected March 2010 release.

According to the company, the surgical platform has been designed from scratch as a combined platform for work on the anterior and posterior eye segments, as well as functioning as a pure phaco machine with permanent upgrade possibilities to the posterior segment. They claims that it fulfils the requirements of the most modern clinics in addition to meeting the challenges facing developing regions.

For further information, visit the company’s website at www.oertli-faros.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.